Improving access to HIV treatment and prevention for vulnerable populations.
ICAP Clinical Trials Unit
This study is all about making it easier for people at high risk of HIV, especially in places like sub-Saharan Africa and the U.S., to get the treatment and prevention they need, focusing on communities like Black and Latino men who have sex with men, women of color, and young people.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10975364 on NIH RePORTER |
What this research studies
This research focuses on enhancing access to HIV treatment and prevention strategies for populations at high risk, particularly in sub-Saharan Africa and the United States. The ICAP Clinical Trials Unit will conduct clinical trials at multiple sites, including New York City, Eswatini, and Kenya, targeting groups such as Black and Latino men who have sex with men, women of color, and adolescents. The approach involves tailoring interventions to meet the specific needs of these communities, aiming to increase awareness and access to HIV services. By engaging with local populations, the research seeks to address barriers to care and improve health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for participation include Black and Latino men who have sex with men, women of color, adolescents, and individuals living in high-prevalence areas.
Not a fit: Patients who are not part of the targeted high-risk groups or those living outside the study locations may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase access to HIV treatment and prevention services for vulnerable populations, ultimately reducing new infections.
How similar studies have performed: Previous research has shown success in improving HIV treatment access and outcomes in similar high-risk populations, indicating that this approach is both relevant and potentially effective.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: El-Sadr, Wafaa M. — Columbia University Health Sciences
- Study coordinator: El-Sadr, Wafaa M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.